VREOD
Vireo Growth Inc.
$9.56
-0.48 (-4.78%)
2 Down Days
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.56
Open$10.07
Day$9.56–10.07
52W$0.32–13.77
Avg vol 30d118K
Short int93 · 1.0d
Short vol21%
Last earningsApr 14, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +499% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+499% above
+
Price vs 50-day avg
+99% above
◦
RSI (14)
59 · neutral
−
MACD trend
negative
◦
52-week position
69% · mid-range
Sentiment · smart money
Bullish
+
Institutional flow · +1 funds added
◦
Trend (MA cross)
50d $5 › 200d $2 — 50d above 200d
+
Institutional flow
+1 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.00% of float · ▼ -99.9% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — 13F breadth
Fundamentals
Strong
+
Revenue growth · +170% Y/Y
+
Revenue growth
+170% Y/Y
+
Gross margin
47%, contracting
+
EPS growth
+44% Y/Y
−
Free cash flow
$-24.6M
−
Balance sheet
net debt $58.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$13.22B
Shares
1,360,813,852
CIK
1771706
CUSIP
92767B105
Website
Visit website
Investor Relations
Investor relations
Up next
Next earnings call
Jul 17, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+499% above
Bullish
Price vs 50-day avg
+99% above
Bullish
RSI (14)
59 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
69% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -99.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $10 · 69%
52-wk high $14
vs 200-day avg +499%
vs 50-day avg +99%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VREOD
this stock
Vireo Growth Inc.
|
$13.22B | +1459.5% | +170.4% | — | 0.0% |
|
GALDY
Galderma Group AG/ADR
|
$53.33B | +9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.35B | -7.7% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.0%
- Net QoQ
- +10.0K sh
- Top holder
- RESOURCES MANAGEMENT CORP…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VREOD | -4.5% | +2170.8% | +1548.3% | -4.8% | +1459.5% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | -6.3% | +2172.3% | +1540.3% | -3.5% | +1450.0% |